Close

SPATA2L

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

SPATA2L (Spermatogenesis Associated 2 Like) is a Protein Coding gene. Among its related pathways are Necroptosis. An important paralog of this gene is SPATA2.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-CQ2857 Anti-SPATA2L (CBXS-5583) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXS-5583 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ2858 Anti-SPATA2L (CBXS-4066) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXS-4066 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ2859 Anti-SPATA2L (CBXS-4394) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXS-4394 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ2860 Anti-SPATA2L (CBXS-4904) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXS-4904 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ6281 Anti-SPATA2L (CBXS-5583) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXS-5583 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ6282 Anti-SPATA2L (CBXS-4066) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXS-4066 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ6283 Anti-SPATA2L (CBXS-4394) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXS-4394 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ6284 Anti-SPATA2L (CBXS-4904) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXS-4904 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.